Van Hulzen Asset Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.99M	Buy	72,270 +80	+0.1%	+$5.52K	0.42%	58
2025 Q1	$5.01M	Sell	72,190 -67	-0.1%	-$4.65K	0.46%	56
2024 Q4	$6.22M	Buy	72,257 +356	+0.5%	+$30.6K	0.45%	58
2024 Q3	$8.56M	Buy	71,901 +11	+0%	+$1.31K	0.62%	46
2024 Q2	$10.3M	Hold	71,890	–	–	0.69%	47
2024 Q1	$9.23M	Buy	71,890 +90	+0.1%	+$11.6K	0.61%	49
2023 Q4	$7.43M	Hold	71,800	–	–	0.52%	52
2023 Q3	$6.53M	Sell	71,800 -854	-1%	-$77.7K	0.5%	55
2023 Q2	$5.88M	Sell	72,654 -546	-0.7%	-$44.2K	0.5%	52
2023 Q1	$5.83M	Buy	+73,200	New	+$5.83M	0.55%	50
2022 Q4	–	Sell	-73,200	Closed	-$3.65M	–	298
2022 Q3	$3.65M	Hold	73,200	–	–	0.45%	62
2022 Q2	$4.08M	Hold	73,200	–	–	0.49%	55
2022 Q1	$4.06M	Hold	73,200	–	–	0.43%	63
2021 Q4	$4.1M	Sell	73,200 -2,900	-4%	-$162K	0.45%	62
2021 Q3	$3.65M	Hold	76,100	–	–	0.54%	51
2021 Q2	$3.19M	Hold	76,100	–	–	0.48%	55
2021 Q1	$2.57M	Hold	76,100	–	–	0.41%	62
2020 Q4	$2.66M	Hold	76,100	–	–	0.4%	61
2020 Q3	$2.64M	Hold	76,100	–	–	0.4%	60
2020 Q2	$2.49M	Sell	76,100 -1,000	-1%	-$32.7K	0.37%	54
2020 Q1	$2.32M	Hold	77,100	–	–	0.5%	49
2019 Q4	$2.23M	Hold	77,100	–	–	0.43%	58
2019 Q3	$1.99M	Hold	77,100	–	–	0.42%	51
2019 Q2	$1.97M	Sell	77,100 -1,600	-2%	-$40.8K	0.43%	52
2019 Q1	$2.06M	Hold	78,700	–	–	0.55%	46
2018 Q4	$1.81M	Hold	78,700	–	–	0.53%	51
2018 Q3	$1.86M	Buy	78,700 +1,600	+2%	+$37.7K	0.49%	54
2018 Q2	$1.78M	Hold	77,100	–	–	0.53%	54
2018 Q1	$1.9M	Hold	77,100	–	–	0.58%	56
2017 Q4	$2.07M	Buy	77,100 +4,100	+6%	+$110K	0.63%	53
2017 Q3	$1.76M	Hold	73,000	–	–	0.59%	53
2017 Q2	$1.57M	Buy	+73,000	New	+$1.57M	0.62%	50